Copper ions, silver ions, and various other chemicals were being tested for effectively killing the COVID-19 virus on the fabric within some hours of exposure. Several companies have developed new technologies which claim to kill the COVID-19 virus up to 99.9% within the time frame of thirty minutes to two hours. Several companies have been a success and have patented their technologies, passing all the tests and checks conducted by regulatory and health bodies of regions and countries. Some of the key companies involved in developing anti-viral technology fabrics are HeiQ Materials AG, Polygiene, Rudolf GmbH, and HealthGaurd Corporation Pty. Ltd.
Anti-Viral Fabric Market Industry Overview
The global Anti-Viral Fabric Market is expected to grow at a significant rate in various end-use applications with a total addressable market size of $226.92 billion in 2020. Face masks are the leading segment in the anti-viral fabric adoption rate during the forecast years, 2021-2026. Face masks account for the global total addressable market of $73.50 billion in 2020.
Market Segmentation
Anti-Viral Products Market by Product
The anti-viral fabric market has been segmented based on products, namely, face masks, bed linen and spreads, PPE, bath/toilet linen, kitchen linen, upholstery, and flooring linen. The face masks segment is estimated to dominate the global anti-viral fabric market. Face masks are one of the essential items of the new normal lifestyle since 2020. Various companies are coming up with new anti-viral technologies using various new types of advanced materials and technologies to develop anti-viral fabrics for face masks fabrics.
Anti-Viral Products Market by Region
The regions discussed in this report include North America, Europe, Asia-Pacific, and Rest-of-the-World. The study showcases detailed driving factors promoting the adoption of anti-viral fabrics in the regions and an extensive list of potential market players of the regions.
Asia-Pacific is expected to account for the highest share of the global anti-viral fabric market, owing to a significant number of companies based in the region, increased spending by textiles R&D centers, and wide adoption of face masks driven by a large population factor.
The Asia-Pacific region is the largest and most prominent developer, manufacturer, and exporter of textiles across the globe. The region has the largest market share for more than 50% of the textile industry.
Key Market Players and Competition Synopsis
Some of the key companies operating in the market, include SQ Group, Donear Industries Ltd., Peter England, HeiQ Materials AG, KARMAN, Hollander Sleep Products, D’décor Home Fabrics Pvt. Ltd., Berger Paints, Polygiene, Diesel S.p.A, Bedgear, HealthGuard Corporation Pvt. Ltd., Carrington Textiles Ltd., Takisada-Nagoya Co., Ltd., Ascend Performance Materials, Rudolf GmbH, Welspun, and Milliken & Company.
Request Sample - https://bisresearch.com/requestsample?id=1139&type=download
How This Report Can Add Value -
Product/Innovation Strategy: The product segment helps the readers in understanding the different types of anti-viral fabric products and their market potential globally. The study showcases the overall total addressable market for various products and their adoption rate for anti-viral technology during the forecast years 2021-2026.
Key questions answered in the Report
• What are the futuristic trends in this market, and how is the market expected to change over the forecast years 2021-2026?
• What are the key drivers and challenges faced by the companies that are currently working in the global anti-viral fabric market?
• How is the anti-viral fabric market expected to grow during the forecast period 2021-2026?
• What are the opportunities for the companies to expand their businesses in the global anti-viral fabric market?
• Which region is expected to lead the global anti-viral fabric market by 2026?
• What are the key developmental strategies implemented by the key players to sustain in this highly competitive market?
• What is the adoption rate of anti-viral products in the global market during the forecast period 2021-2026?
BIS Research Offerings - https://bisresearch.com/our-offerings/subscriptions
You May Also Like -
Green Hydrogen Market - Analysis And In-Depth Research On Market Size, Trends And Forecast upto 2031
The Business Research Company published its Anti-Viral Drug Therapy Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global anti-viral drug therapy market.
The report covers the anti-viral drug therapy market’s segments- by drug class: DNA polymerase inhibitors; reverse transcriptase inhibitors; protease inhibitors; neuraminidase inhibitors; others and by application: HIV; hepatitis; herpes; influenza; others.View Complete Report: https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market-global-report-2020-2030-covid-19-implications-and-growthAnti-Viral Drug Therapy Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It covers all the regions, key developed countries and major emerging markets.
The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.Companies in the anti-viral drug therapy market are continuously innovating through technological advancements to develop drugs to treat different viral infections.
Technological advances in the pharmaceutical sector include development of nucleic acid vaccines that are DNA- and RNA-based, which enable the human body to produce the vaccine antigen.Few Points From Table Of Content 1.
The Business Research Company published its Anti-Viral Drug Therapy Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Anti-Viral Drug Therapy market.
The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the Anti-Viral Drug Therapy market’s segments- 1) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others2) By Application: HIV, Hepatitis, Herpes, Influenza, Others.
View Complete Report:https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market-global-report-2020-2030-covid-19-implications-and-growthAnti-Viral Drug Therapy Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.The global anti-viral drug therapy market is expected to grow from $52.2 billion in 2019 to about $59.9 billion in 2020 as there is a surge in demand for antiretroviral drugs used in the treatment of COVID-19 patients.
The market is expected to stabilize and reach $62.6 billion at a CAGR of 4.6% through 2023.Companies in the anti-viral drug therapy market are continuously innovating through technological advancements to develop drugs to treat different viral infections.
